Arizona State University

This Week in PLOS

In PLOS this week: ramifications of sexual recombination in bacteria, Mycobacterium leprae genome sequences, and more.

The Biomedical Advanced Research and Development Authority aims to produce at least two US Food and Drug Administration-cleared tests.

This Week in Science

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.

The researchers also found fixed variants in the tortoise genome linked to the immune system, which may help manage the health of the threatened species.

New data from Peregrine Pharmaceuticals, along with other recent research, suggests that surface proteins can be used to isolate cancer-specific exosomes to detect the presence of a tumor.

Researchers showed it could differentiate pancreatic cancer cases from controls with high sensitivity, and believe it could work similarly for other cancers or in infectious disease.

Maybe Next Time

Robert Cook-Deegan and Subhashini Chandrasekharan discuss genetic testing patents in the New England Journal of Medicine.

The funding is part of the NHGRI Genome Technology Program, which promotes new methods, technology, and instruments for sequencing and functional genomics.

Researchers led by MIT's Jim Collins have built upon their paper-based Ebola test and are hoping to find a partner to help scale production and manufacturing of the test.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.